Ardent Health, Inc. (NYSE:ARDT - Get Free Report)'s share price reached a new 52-week low on Friday . The company traded as low as $11.27 and last traded at $11.36, with a volume of 197698 shares changing hands. The stock had previously closed at $11.58.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on ARDT. Guggenheim raised their price objective on shares of Ardent Health from $16.00 to $18.00 and gave the company a "buy" rating in a research note on Friday, May 9th. Mizuho dropped their price objective on shares of Ardent Health from $19.00 to $18.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $21.00 price objective on shares of Ardent Health in a research note on Thursday, May 15th. Stephens reiterated an "overweight" rating and issued a $21.00 target price on shares of Ardent Health in a report on Tuesday, May 20th. Finally, Bank of America downgraded shares of Ardent Health from a "neutral" rating to an "underperform" rating and lowered their target price for the company from $15.50 to $14.60 in a report on Wednesday. One investment analyst has rated the stock with a sell rating, one has given a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Ardent Health presently has a consensus rating of "Moderate Buy" and an average price target of $20.30.
Check Out Our Latest Analysis on ARDT
Ardent Health Price Performance
The business's 50-day moving average price is $13.94 and its 200 day moving average price is $13.99. The company has a quick ratio of 1.98, a current ratio of 2.12 and a debt-to-equity ratio of 0.70. The company has a market capitalization of $1.62 billion and a P/E ratio of 6.95.
Ardent Health (NYSE:ARDT - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.29 EPS for the quarter, beating analysts' consensus estimates of $0.21 by $0.08. Ardent Health had a net margin of 3.73% and a return on equity of 16.07%. The company had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.50 billion. Analysts anticipate that Ardent Health, Inc. will post 1.23 EPS for the current fiscal year.
Institutional Investors Weigh In On Ardent Health
Several hedge funds have recently bought and sold shares of the stock. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Ardent Health during the fourth quarter worth approximately $27,000. Morse Asset Management Inc bought a new stake in Ardent Health in the first quarter valued at $36,000. Deutsche Bank AG boosted its holdings in Ardent Health by 1,251.9% in the fourth quarter. Deutsche Bank AG now owns 2,866 shares of the company's stock valued at $49,000 after acquiring an additional 2,654 shares in the last quarter. Quarry LP boosted its holdings in Ardent Health by 1,519.4% in the first quarter. Quarry LP now owns 5,020 shares of the company's stock valued at $69,000 after acquiring an additional 4,710 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new stake in Ardent Health in the first quarter valued at $142,000.
About Ardent Health
(
Get Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ardent Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.
While Ardent Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.